# Final Report: Idea 80

## Final ELO Score: 1218.0

## Final Hypothesis

**Title**: Broad Siderophore-Rifabutin Conjugate Panel with Self-Immolative Disulfides for H. influenzae & Moraxella

**Key Idea**: A suite of haemin, protoporphyrin, and ferrichrome conjugates exploit multiple heme-uptake systems, overcoming siderophore receptor variation; disulfide linkers ensure cytosolic rifabutin release.

**Paragraph**: Multi-ligand strategy hedges against receptor heterogeneity in clinical isolates, while preserving selective uptake.

**Approach**: Synthesis; uptake competition assays; genomically diverse strain panel; chinchilla otitis media co-pathogen model.

**Key References**: Morton 2012; Miethke 2007; Fosgerau 2015; NEW—Adamiak et al., ACS Infect. Dis., 2021 (multi-ligand sideromycins) [Adamiak 2021].  
Modifications: Added multi-siderophore repertoire to limit resistance.

────────────────────────────────────────────────────────
IDEA 45  
────────────────────────────────────────────────────────

## Comprehensive Analysis

This document provides a full analysis of the idea, including its evolution, strengths, weaknesses, and potential applications. Below we trace the development of this idea through each phase of the research process.

## Evolution History

The idea underwent several iterations during the research process:

## Detailed Breakdown

### Title

Broad Siderophore-Rifabutin Conjugate Panel with Self-Immolative Disulfides for H. influenzae & Moraxella

### Key Idea

A suite of haemin, protoporphyrin, and ferrichrome conjugates exploit multiple heme-uptake systems, overcoming siderophore receptor variation; disulfide linkers ensure cytosolic rifabutin release.

### Detailed Explanation

Multi-ligand strategy hedges against receptor heterogeneity in clinical isolates, while preserving selective uptake.

### Implementation Approach

Synthesis; uptake competition assays; genomically diverse strain panel; chinchilla otitis media co-pathogen model.

### Key References

Morton 2012; Miethke 2007; Fosgerau 2015; NEW—Adamiak et al., ACS Infect. Dis., 2021 (multi-ligand sideromycins) [Adamiak 2021].  
Modifications: Added multi-siderophore repertoire to limit resistance.

────────────────────────────────────────────────────────
IDEA 45  
────────────────────────────────────────────────────────

## Complete Evolution History

This section documents the complete evolution of the idea through each phase of the research process.

### 1. Evolution (Round 4)
**Timestamp:** 2025-05-07 10:43:26



### 2. Reflection (Round 4)
**Timestamp:** 2025-05-07 10:44:53



### 3. Proximity Check (Round 4)
**Timestamp:** 2025-05-07 10:45:31



### 4. Ranking (Round 4)
**Timestamp:** 2025-05-07 10:45:39



### 5. Round Summary (Round 4)
**Timestamp:** 2025-05-07 10:46:18



### 6. Tournament Results
**Timestamp:** 2025-05-07 11:00:51

**ELO Score:** 1218.0



### 7. Final Tournament Results
**Timestamp:** 2025-05-07 11:00:51

**ELO Score:** 1218.0



## Citations

- Adamiak 2021
